www.fdanews.com/articles/167751-fda-scolds-pet-drugmaker-for-poor-data-integrity
FDA Scolds PET Drugmaker for Poor Data Integrity
October 10, 2014
The FDA slapped positron emission tomography (PET) drug manufacturer Cardinal Health with a Form 483 for poor data integrity and investigations into quality problems.
Drug GMP Report